These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6390829)

  • 1. The effect of pretransplant stored donor-specific blood transfusion on renal allograft survival in one-haplotype living-related transplant recipients.
    Whelchel JD; Curtis JJ; Barger BO; Luke RG; Diethelm AG
    Transplantation; 1984 Dec; 38(6):654-6. PubMed ID: 6390829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pretransplant stored donor-specific blood transfusions on early renal allograft survival in one-haplotype living related transplants.
    Whelchel JD; Shaw JF; Curtis JJ; Luke RG; Diethelm AG
    Transplantation; 1982 Dec; 34(6):326-9. PubMed ID: 6760491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor transplants.
    Cecka JM
    Clin Transpl; 1995; ():363-77. PubMed ID: 8794280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
    Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
    Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of blood transfusions on renal transplantation: study of 191 consecutive first transplants from living related donors.
    Solheim BG; Flatmark A; Halvorsen S; Jervell J; Pape J; Thorsby E
    Transplantation; 1980 Oct; 30(4):281-4. PubMed ID: 6449767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transfusion effect.
    Cecka JM
    Clin Transpl; 1987; ():287-301. PubMed ID: 3154420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
    Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
    Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-year experience with donor blood transfusion protocols for living-donor renal transplantation.
    Glass NR; Miller DT; Sollinger HW; Belzer FO
    Transplantation; 1985 Jun; 39(6):615-9. PubMed ID: 3890291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved allograft survival in nonidentical living related donor transplants using donor-specific blood transfusions.
    Mendez R; Mendez RG; Iwaki YI; Kinukawa T; Bogaard TP; Self BA; Terasaki PI
    J Urol; 1985 Mar; 133(3):383-5. PubMed ID: 3973987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions.
    Flechner SM; Kerman RH; Van Buren C; Kahan BD
    Transplantation; 1984 Jan; 37(1):73-6. PubMed ID: 6229913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation in the northwest region of England--experience of 1,132 transplants in 21 years.
    Dyer PA; Martin S; Mallick NP; Gokal R; Johnson RW
    Clin Transpl; 1989; ():201-13. PubMed ID: 2487567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pre-transplant blood transfusions and haemodialysis on the survival of first kidney grafts from living related donors.
    Solheim BG; Flatmark A; Halvorsen S; Jervell J; Pape J; Thorsby E
    Scand J Urol Nephrol Suppl; 1980; 54():63-6. PubMed ID: 7013047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early rejection episodes.
    Cecka JM; Terasaki PI
    Clin Transpl; 1989; ():425-34. PubMed ID: 2487611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.